AI-Powered Cancer Vaccine Saves Dog, Offers Hope for Human Treatments

In a groundbreaking development, a Sydney tech entrepreneur utilized artificial intelligence to create a personalized mRNA cancer vaccine for his dog, Rosie, a staffy-shar pei mix. The experimental treatment has shown remarkable results, shrinking Rosie’s tumors and offering a potential pathway for future cancer therapies in both animals and humans.

A Desperate Search for a Cure

Paul Conyngham adopted Rosie in 2019, shortly before pandemic lockdowns began. In 2024, Rosie was diagnosed with aggressive mast cell cancer. Despite undergoing chemotherapy and surgery, the tumors persisted and her condition worsened. Determined to uncover a solution, Conyngham turned to AI.

ChatGPT and Genomic Sequencing

Conyngham, an electrical and computing engineer and co-founder of Core Intelligence Technologies, began exploring potential treatments with the help of OpenAI’s ChatGPT. The chatbot suggested immunotherapy, leading him to the University of New South Wales Ramaciotti Centre for Genomics. He funded $3,000 for Rosie’s genomic sequencing, hoping to pinpoint the cause of her cancer.

AI-Driven Analysis and Vaccine Design

After the genomic sequencing, Conyngham used AI tools, including Google’s DeepMind’s AlphaFold, to analyze the data and identify mutated proteins that could be targeted for treatment. He likened the process to comparing a healthy engine to one with significant wear and tear, allowing him to identify the specific areas of damage.

Overcoming Obstacles and Collaboration

When a pharmaceutical company refused to provide a promising immunotherapy drug for compassionate apply, Conyngham collaborated with Pall Thordarson, director of the UNSW’s RNA Institute. Thordarson used Conyngham’s AI-generated data – a half-page formula – to develop a custom mRNA vaccine for Rosie in less than two months.

First-of-Its-Kind Vaccine and Promising Results

“This is the first time a personalized cancer vaccine has been designed for a dog,” Thordarson stated. The vaccine has yielded stunning results, with Rosie’s tennis ball-sized tumor on her hock halving in size. Researchers are amazed by the treatment’s potential and its implications for human cancer therapy.

Implications for Personalized Medicine

This case demonstrates the potential of personalized medicine and the speed at which mRNA technology can be applied to develop targeted treatments. As Thordarson noted, Rosie’s case shows that personalized medicine can be highly effective and implemented quickly, with potential applications for human patients.

Key Takeaways

• AI played a crucial role in identifying potential cancer targets and designing a personalized vaccine.
• mRNA technology enabled the rapid development of a custom vaccine.
• This case marks the first time a personalized cancer vaccine has been created for a dog.
• The success of this treatment offers hope for advancements in human cancer therapies.